Skip to main content
Bafna Pharmaceuticals Limited logo

Bafna Pharmaceuticals Limited — Investor Relations & Filings

Ticker · BAFNAPH ISIN · INE878I01022 LEI · 984500D03E2C7Y5EE587 BSE.NS Manufacturing
Filings indexed 249 across all filing types
Latest filing 2020-07-31 Regulatory Filings
Country IN India
Listing BSE.NS BAFNAPH

About Bafna Pharmaceuticals Limited

http://bafnapharma.com/

Bafna Pharmaceuticals Limited specializes in the development, manufacture, and marketing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities certified by WHO-GMP standards, ensuring high-quality production of finished dosage forms including tablets, capsules, syrups, and suspensions. Its therapeutic portfolio spans multiple categories such as anti-infectives, analgesics, cardiovascular, gastrointestinal, and vitamins. The organization serves both domestic and international markets, with a significant presence in emerging regions across Africa, Southeast Asia, and the CIS. In addition to its proprietary product line, the company provides comprehensive contract manufacturing and formulation development services, leveraging its technical expertise and regulatory compliance to meet global healthcare requirements.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2020-07-31 English
Related Party Transactions
Regulatory Filings
2020-07-22 English
Book Closure
AGM Information Classification · 95% confidence The document is a notification regarding the book closure dates for the purpose of the Annual General Meeting (AGM) of Bafna Pharmaceuticals Limited. It references Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to the closure of the register of members for AGM purposes. The document does not contain financial statements, management discussion, or detailed report content. It is a formal announcement informing stock exchanges and shareholders about the book closure period and the AGM date. The document length is short (3132 characters), and it serves as an announcement rather than the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related official notices about the AGM.
2020-06-29 English
Resignation
Regulatory Filings
2020-06-25 English
Financial Result Updates
Regulatory Filings
2020-06-25 English
Outcome of Board Meeting
Regulatory Filings
2020-06-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.